Related Experiment Videos
MLL-ENL cooperates with SCF to transform primary avian multipotent cells
Cathleen E Schulte1, Marieke von Lindern, Peter Steinlein
1Leukaemia Research Fund Centre, Institute of Cancer Research, London, UK. schulte@nt.imp.univie.ac.at
The EMBO Journal
|August 10, 2002
Summary
Chromosomal translocations involving the MLL gene create fusion proteins that drive acute leukaemias. These MLL fusion proteins promote the sustained growth of immature hematopoietic stem cells, crucial for leukaemia development.
Area of Science:
- Hematology
- Molecular Biology
- Cancer Research
Background:
- Chromosomal translocations targeting the MLL gene produce fusion proteins implicated in acute leukaemias.
- Understanding how these MLL fusion proteins affect hematopoietic progenitor cells is critical for leukaemia research.
Purpose of the Study:
- To investigate the impact of MLL-AF9 and MLL-ENL fusion proteins on the proliferation and differentiation of primary hematopoietic progenitors.
- To determine the role of stem cell factor (SCF) in sustaining the growth of MLL fusion protein-transformed cells.
Main Methods:
- Introduction of MLL-AF9 and MLL-ENL fusion proteins into primary chicken bone marrow cells.
- Culturing transformed cells in the presence and absence of stem cell factor (SCF).
- Analysis of clonal cultures and induction of differentiation using a two-step protocol.
Main Results:
- Both MLL-AF9 and MLL-ENL induced sustained outgrowth of immature hematopoietic cells, dependent on SCF.
- Transformed cells exhibited multipotency, expressing markers for erythroid, myeloid, lymphoid, and stem cells, with extended in vitro lifespan.
- MLL-ENL transformed progenitors could undergo terminal erythroid or myeloid differentiation upon SCF withdrawal.
- MLL-ENL cooperated with v-Sea to induce multilineage leukaemia in vivo.
Conclusions:
- MLL fusion proteins promote the self-renewal of immature hematopoietic progenitors in an SCF-dependent manner.
- These transformed progenitors retain multipotency and can be induced to differentiate, suggesting a block in normal differentiation pathways.
- Activated receptor tyrosine kinases can cooperate with MLL fusion proteins to induce leukaemia, highlighting potential therapeutic targets.